Clinical Trials Browser

Phase 1 × Central Nervous System Neoplasms × mafosfamide × Clear all

NCT00031928 2015-04-30

Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors

Phase 1 Completed

Central Nervous System Neoplasms, Meningeal Carcinomatosis